Home › Kanser sa Pantog › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Kanser sa Pantog sa Philadelphia, PA
Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Nagre-recruitPhase 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi ang layo
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
Nagre-recruit
- Abramson Cancer Center, Philadelphia
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Nagre-recruitPhase 3
- Fox Chase Cancer Center, Philadelphia
- Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi ang layo
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Nagre-recruitPhase 2
- MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi ang layo
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Nagre-recruitPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi ang layo
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Nagre-recruit
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Nagre-recruitPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- University of Pennsylvania, Philadelphia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Nagre-recruitPhase 2
- University of Pennsylvania, Philadelphia
- Midlantic Urology (Solaris), Bala-Cynwyd · 5 mi ang layo
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Nagre-recruitPhase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi ang layo
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi ang layo
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Nagre-recruitPhase 1/2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- Thomas Jefferson University, Philadelphia
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Nagre-recruitPhase 1
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- University of Pennsylvania, Philadelphia
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Nagre-recruit
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Philadelphia
Pag-aaral para sa Kanser sa Pantog sa ibang lungsod
- New York City, NY35 pag-aaral
- Houston, TX31 pag-aaral
- Nashville, TN31 pag-aaral
- Dallas, TX27 pag-aaral
- Washington, DC26 pag-aaral
- Boston, MA26 pag-aaral
- Baltimore, MD24 pag-aaral
- Los Angeles, CA24 pag-aaral
- St. Louis, MO22 pag-aaral
- Seattle, WA21 pag-aaral
- Chicago, IL21 pag-aaral
- Edison, NJ21 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.